Profound Medical Corp. (NASDAQ: PROF) reported Q4 EPS of $0.42, $0.72 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.97 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.